 Emily Bates
Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Potassium Channels, Inwardly Rectifying | 6 | 2025 | 44 | 2.890 |
Why?
| | Palate | 5 | 2026 | 39 | 2.770 |
Why?
| | Wings, Animal | 5 | 2019 | 37 | 1.790 |
Why?
| | Tubulin | 4 | 2020 | 147 | 1.770 |
Why?
| | Cannabidiol | 3 | 2026 | 136 | 1.620 |
Why?
| | Cleft Palate | 6 | 2026 | 89 | 1.480 |
Why?
| | Drosophila | 3 | 2019 | 166 | 1.350 |
Why?
| | Mesoderm | 3 | 2025 | 150 | 1.200 |
Why?
| | Adenoviruses, Human | 3 | 2026 | 26 | 1.100 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2025 | 43 | 1.090 |
Why?
| | Drosophila Proteins | 4 | 2019 | 212 | 1.080 |
Why?
| | Genetic Vectors | 4 | 2026 | 337 | 0.990 |
Why?
| | Neural Crest | 3 | 2026 | 126 | 0.990 |
Why?
| | Ion Channels | 2 | 2019 | 129 | 0.980 |
Why?
| | Mice, Knockout | 6 | 2026 | 3125 | 0.860 |
Why?
| | Adenoviridae Infections | 1 | 2023 | 20 | 0.770 |
Why?
| | Gene Regulatory Networks | 1 | 2025 | 320 | 0.760 |
Why?
| | Behavior, Animal | 1 | 2026 | 520 | 0.730 |
Why?
| | Neurons | 5 | 2024 | 1642 | 0.730 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2026 | 675 | 0.690 |
Why?
| | Mice | 18 | 2026 | 18365 | 0.680 |
Why?
| | Mutation, Missense | 2 | 2020 | 340 | 0.680 |
Why?
| | Haploinsufficiency | 2 | 2026 | 55 | 0.660 |
Why?
| | Cerebral Cortex | 2 | 2024 | 465 | 0.660 |
Why?
| | Calcium | 2 | 2024 | 1184 | 0.650 |
Why?
| | Animals | 27 | 2026 | 38109 | 0.620 |
Why?
| | Glioblastoma | 1 | 2023 | 353 | 0.600 |
Why?
| | Lissencephaly | 1 | 2019 | 3 | 0.600 |
Why?
| | Gene Expression Regulation, Developmental | 6 | 2026 | 906 | 0.590 |
Why?
| | Dyneins | 1 | 2019 | 35 | 0.590 |
Why?
| | Genetic Therapy | 1 | 2021 | 313 | 0.590 |
Why?
| | Brain Diseases | 1 | 2019 | 153 | 0.550 |
Why?
| | Drosophila melanogaster | 2 | 2019 | 236 | 0.530 |
Why?
| | Face | 1 | 2018 | 174 | 0.490 |
Why?
| | Body Patterning | 2 | 2018 | 138 | 0.480 |
Why?
| | Microtubules | 4 | 2024 | 286 | 0.440 |
Why?
| | Morphogenesis | 3 | 2023 | 173 | 0.440 |
Why?
| | Brain Neoplasms | 1 | 2023 | 1322 | 0.400 |
Why?
| | Alcohols | 1 | 2013 | 28 | 0.390 |
Why?
| | Capsid Proteins | 2 | 2026 | 95 | 0.380 |
Why?
| | Cleft Lip | 3 | 2026 | 72 | 0.380 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2013 | 70 | 0.370 |
Why?
| | Receptors, Virus | 2 | 2023 | 96 | 0.350 |
Why?
| | Prefrontal Cortex | 2 | 2026 | 328 | 0.340 |
Why?
| | Nitroglycerin | 2 | 2013 | 14 | 0.340 |
Why?
| | Primary Cell Culture | 2 | 2024 | 174 | 0.330 |
Why?
| | Huntington Disease | 3 | 2007 | 61 | 0.330 |
Why?
| | Signal Transduction | 7 | 2024 | 5233 | 0.320 |
Why?
| | Embryo, Mammalian | 3 | 2024 | 232 | 0.320 |
Why?
| | Serotonin 5-HT1 Receptor Antagonists | 1 | 2010 | 2 | 0.320 |
Why?
| | Sumatriptan | 1 | 2010 | 6 | 0.320 |
Why?
| | Hyperalgesia | 2 | 2013 | 131 | 0.310 |
Why?
| | Mutation | 6 | 2019 | 4099 | 0.300 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 592 | 0.280 |
Why?
| | Vasodilator Agents | 1 | 2010 | 331 | 0.270 |
Why?
| | Caenorhabditis elegans | 3 | 2007 | 337 | 0.270 |
Why?
| | Neurogenesis | 2 | 2020 | 157 | 0.270 |
Why?
| | Pregnancy | 5 | 2026 | 7191 | 0.250 |
Why?
| | Mice, Inbred C57BL | 5 | 2026 | 5997 | 0.240 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2018 | 142 | 0.230 |
Why?
| | Capsid | 1 | 2026 | 94 | 0.230 |
Why?
| | Wnt4 Protein | 1 | 2025 | 20 | 0.230 |
Why?
| | Diaphragm | 1 | 2025 | 49 | 0.230 |
Why?
| | Lip | 1 | 2005 | 22 | 0.220 |
Why?
| | Linguistics | 1 | 2005 | 27 | 0.220 |
Why?
| | Motion Perception | 1 | 2005 | 20 | 0.220 |
Why?
| | Eye Movements | 1 | 2005 | 92 | 0.210 |
Why?
| | Speech | 1 | 2005 | 77 | 0.210 |
Why?
| | Histone Deacetylases | 1 | 2006 | 210 | 0.210 |
Why?
| | Sunflower Oil | 1 | 2023 | 7 | 0.200 |
Why?
| | Oncolytic Virotherapy | 2 | 2021 | 13 | 0.200 |
Why?
| | Peptides | 3 | 2007 | 998 | 0.200 |
Why?
| | Administration, Oral | 1 | 2026 | 848 | 0.190 |
Why?
| | Nausea | 1 | 2023 | 111 | 0.190 |
Why?
| | Visual Perception | 1 | 2005 | 183 | 0.190 |
Why?
| | Seroepidemiologic Studies | 1 | 2023 | 172 | 0.190 |
Why?
| | Migraine Disorders | 2 | 2015 | 112 | 0.190 |
Why?
| | Cytoskeleton | 1 | 2024 | 195 | 0.180 |
Why?
| | Cell Movement | 2 | 2019 | 965 | 0.180 |
Why?
| | Adenoviridae | 1 | 2023 | 199 | 0.180 |
Why?
| | Vaping | 1 | 2023 | 66 | 0.180 |
Why?
| | RNA Interference | 2 | 2019 | 476 | 0.180 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2023 | 323 | 0.180 |
Why?
| | Heart | 1 | 2025 | 636 | 0.170 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2023 | 108 | 0.170 |
Why?
| | Cell Culture Techniques | 1 | 2024 | 375 | 0.170 |
Why?
| | Transduction, Genetic | 1 | 2021 | 133 | 0.170 |
Why?
| | Hallucinogens | 1 | 2023 | 109 | 0.170 |
Why?
| | Virus Internalization | 1 | 2021 | 65 | 0.160 |
Why?
| | Nuclear Proteins | 1 | 2006 | 749 | 0.160 |
Why?
| | Genes, Reporter | 1 | 2021 | 276 | 0.160 |
Why?
| | Cannabinoids | 1 | 2023 | 182 | 0.160 |
Why?
| | Neoplasms | 2 | 2021 | 2884 | 0.160 |
Why?
| | Humans | 17 | 2026 | 144957 | 0.160 |
Why?
| | Cognition | 2 | 2026 | 1269 | 0.150 |
Why?
| | Folate Receptor 1 | 1 | 2020 | 17 | 0.150 |
Why?
| | Cell Line, Tumor | 3 | 2023 | 3550 | 0.150 |
Why?
| | Molecular Imaging | 1 | 2019 | 58 | 0.150 |
Why?
| | Genetic Engineering | 1 | 2020 | 93 | 0.150 |
Why?
| | Spleen | 1 | 2021 | 508 | 0.150 |
Why?
| | Organogenesis | 1 | 2019 | 65 | 0.150 |
Why?
| | Animals, Genetically Modified | 2 | 2012 | 250 | 0.140 |
Why?
| | Female | 12 | 2026 | 78376 | 0.140 |
Why?
| | Phenotype | 5 | 2015 | 3164 | 0.140 |
Why?
| | POU Domain Factors | 1 | 2018 | 6 | 0.140 |
Why?
| | Molecular Structure | 1 | 2019 | 501 | 0.140 |
Why?
| | Cells, Cultured | 2 | 2024 | 4155 | 0.140 |
Why?
| | Oligopeptides | 1 | 2020 | 269 | 0.140 |
Why?
| | Pain | 1 | 2023 | 782 | 0.130 |
Why?
| | Cortical Spreading Depression | 3 | 2015 | 9 | 0.130 |
Why?
| | Craniofacial Abnormalities | 1 | 2018 | 76 | 0.130 |
Why?
| | Phylogeny | 1 | 2021 | 1019 | 0.120 |
Why?
| | Potassium | 1 | 2017 | 152 | 0.120 |
Why?
| | Skull | 1 | 2018 | 158 | 0.120 |
Why?
| | Male | 9 | 2026 | 72406 | 0.120 |
Why?
| | Membrane Potentials | 1 | 2017 | 280 | 0.120 |
Why?
| | Transcription Factors | 3 | 2026 | 1742 | 0.120 |
Why?
| | RNA | 1 | 2023 | 940 | 0.120 |
Why?
| | Cannabis | 1 | 2023 | 509 | 0.120 |
Why?
| | Valproic Acid | 1 | 2015 | 48 | 0.120 |
Why?
| | Cell Line | 1 | 2021 | 2882 | 0.120 |
Why?
| | Nervous System | 1 | 2015 | 70 | 0.110 |
Why?
| | Amides | 1 | 2015 | 101 | 0.110 |
Why?
| | Cell Size | 1 | 2015 | 92 | 0.110 |
Why?
| | Physical Stimulation | 2 | 2013 | 68 | 0.100 |
Why?
| | Casein Kinase Idelta | 1 | 2013 | 1 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2540 | 0.100 |
Why?
| | Anticonvulsants | 1 | 2015 | 242 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2013 | 196 | 0.100 |
Why?
| | Gene Expression | 2 | 2010 | 1490 | 0.100 |
Why?
| | Brain | 2 | 2019 | 2941 | 0.090 |
Why?
| | Liver | 1 | 2021 | 1888 | 0.090 |
Why?
| | Embryo, Nonmammalian | 1 | 2012 | 173 | 0.090 |
Why?
| | Lung | 2 | 2023 | 4109 | 0.090 |
Why?
| | Spinal Cord | 2 | 2013 | 382 | 0.080 |
Why?
| | Rats | 1 | 2019 | 5614 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2012 | 635 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2013 | 434 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4569 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2609 | 0.070 |
Why?
| | Plicamycin | 1 | 2007 | 3 | 0.070 |
Why?
| | Lithium Chloride | 1 | 2007 | 13 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2015 | 2499 | 0.060 |
Why?
| | Hot Temperature | 1 | 2010 | 407 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2015 | 2050 | 0.060 |
Why?
| | Huntingtin Protein | 1 | 2006 | 13 | 0.060 |
Why?
| | Carbocyanines | 1 | 2006 | 36 | 0.060 |
Why?
| | Chromosome Disorders | 1 | 2026 | 45 | 0.060 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2026 | 79 | 0.060 |
Why?
| | Nerve Degeneration | 1 | 2006 | 48 | 0.060 |
Why?
| | CREB-Binding Protein | 1 | 2006 | 34 | 0.060 |
Why?
| | Chromosome Deletion | 1 | 2026 | 124 | 0.060 |
Why?
| | Neuroprotective Agents | 1 | 2007 | 143 | 0.060 |
Why?
| | Sleep | 1 | 2013 | 901 | 0.060 |
Why?
| | Hydroxamic Acids | 1 | 2006 | 94 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1718 | 0.060 |
Why?
| | Sound Spectrography | 1 | 2005 | 16 | 0.060 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 145 | 0.060 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2025 | 46 | 0.060 |
Why?
| | Cryoelectron Microscopy | 1 | 2026 | 222 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 983 | 0.050 |
Why?
| | Task Performance and Analysis | 1 | 2005 | 198 | 0.050 |
Why?
| | Helminth Proteins | 1 | 2002 | 24 | 0.050 |
Why?
| | Repressor Proteins | 1 | 2026 | 437 | 0.050 |
Why?
| | Movement | 1 | 2005 | 294 | 0.050 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2025 | 219 | 0.050 |
Why?
| | Neurotoxicity Syndromes | 1 | 2002 | 38 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2006 | 826 | 0.050 |
Why?
| | Analysis of Variance | 1 | 2005 | 1311 | 0.050 |
Why?
| | Nicotine | 1 | 2023 | 332 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 587 | 0.040 |
Why?
| | Aging | 2 | 2007 | 1966 | 0.030 |
Why?
| | Mice, Nude | 1 | 2020 | 688 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 1998 | 56 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1998 | 57 | 0.030 |
Why?
| | Insect Proteins | 1 | 1998 | 40 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2006 | 2832 | 0.030 |
Why?
| | Motor Endplate | 1 | 2015 | 15 | 0.030 |
Why?
| | Neuromuscular Junction | 1 | 2015 | 65 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2015 | 66 | 0.030 |
Why?
| | Protein Stability | 1 | 2015 | 178 | 0.030 |
Why?
| | Polymerization | 1 | 2015 | 130 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2015 | 214 | 0.030 |
Why?
| | Axons | 1 | 2015 | 201 | 0.030 |
Why?
| | Trigeminal Nuclei | 1 | 2013 | 6 | 0.020 |
Why?
| | Motor Neurons | 1 | 2015 | 234 | 0.020 |
Why?
| | Sensory Thresholds | 1 | 2013 | 31 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2013 | 106 | 0.020 |
Why?
| | Sleep Stages | 1 | 2013 | 75 | 0.020 |
Why?
| | Genetic Testing | 1 | 2015 | 482 | 0.020 |
Why?
| | Pedigree | 1 | 2013 | 514 | 0.020 |
Why?
| | Vasoconstriction | 1 | 2013 | 217 | 0.020 |
Why?
| | Synapses | 1 | 2015 | 439 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2157 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2931 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2013 | 252 | 0.020 |
Why?
| | Astrocytes | 1 | 2013 | 224 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2015 | 579 | 0.020 |
Why?
| | Motor Activity | 1 | 2015 | 722 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 744 | 0.020 |
Why?
| | Vasodilation | 1 | 2013 | 523 | 0.020 |
Why?
| | Child, Preschool | 1 | 2023 | 11799 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2007 | 202 | 0.010 |
Why?
| | Drug Combinations | 1 | 2007 | 392 | 0.010 |
Why?
| | Longevity | 1 | 2007 | 173 | 0.010 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2007 | 210 | 0.010 |
Why?
| | Proline-Rich Protein Domains | 1 | 2002 | 1 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2002 | 510 | 0.010 |
Why?
| | Adult | 1 | 2005 | 40506 | 0.010 |
Why?
| | Activin Receptors | 1 | 1998 | 3 | 0.010 |
Why?
| | Genes, Insect | 1 | 1998 | 22 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 1998 | 66 | 0.010 |
Why?
| | Microscopy, Electron, Scanning | 1 | 1998 | 199 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 1998 | 122 | 0.010 |
Why?
| | Larva | 1 | 1998 | 242 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2002 | 1496 | 0.010 |
Why?
| | Protein Conformation | 1 | 1998 | 946 | 0.010 |
Why?
| | Temperature | 1 | 1998 | 679 | 0.010 |
Why?
|
|
Bates's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|